Screening for Social Weaknesses and Coordination Course of Cancer Patients

Cancer Clinical Trial

— DEFCOCANCERO  

Official title:

Screening for Social Weaknesses and Coordination Course of Cancer Patients: A New Approach by an Expert System IT

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02369783
• Other study ID #: 2014-05
• Status: Completed
• Phase: N/A
• First received: February 6, 2015
• Last updated: February 25, 2016
• Start date: July 2014
• Est. completion date: February 2015

Study information

• Verified date: February 2016
• Source: Institut de Cancérologie de la Loire
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santéFrance: The Commission nationale de l’informatique et des libertés
• Study type: Interventional

Clinical Trial Summary

The main objective of the study is to validate a methodology with Psychometric tool to measure levels of patients social fragility.

This tool will be dematerialized on a tablet. The answers will be then processed by a decision support algorithm, which automatically send an alert to detection of social fragility of the patient to the nurse navigators.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 71
• Est. completion date: February 2015
• Est. primary completion date: February 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All new patients enter ICLN for a diagnosis of cancer

• Patients who can read French or patients who can not read French, but accepting the translation by a close friend or family

• Patient having signed a free and informed consent

Exclusion Criteria:

• Refusal of participation, major patients protected under guardianship.

• Patient can not read French without possibility of translation by a close friend or family

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• Questionnaire and interview
The aim is to detect social fragility.

Locations

Country	Name	City	State
France	Institut de Cancerologie de la Loire	St Priest en Jarez

Sponsors (1)

Lead Sponsor	Collaborator
Institut de Cancérologie de la Loire

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Questionnaire validity	Outcomes are content validity by expert judges method, appearance validity through a consensus, construct validity through exploratory factor analysis, discriminant validity in relation to the social fragility through univariate analysis, internal validity through factor analysis	1 hour	No